Form D — NewcelX Ltd.
0001213900-26-121840 · filed Nov 18, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $2,875,023
- Reported amount sold
- $2,875,023
- Minimum investment
- $0
- Investors
- 5
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- NewcelX Ltd.
- CIK
- 1783036
- Entity
- Other
- Jurisdiction
- SWITZERLAND
- Year incorporated
- —
- Address
- HOHSTRASSE 1
KLOTEN, Switzerland 8302 - Phone
- 41 44 512 21 50
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Ronen Twito · Executive OfficerKloten, Switzerland Find on LinkedIn ↗
-
Michel Revel · Executive OfficerKloten, Switzerland Find on LinkedIn ↗
-
Kfir Molakandov · Executive OfficerKloten, Switzerland Find on LinkedIn ↗
-
Omri Hagai · Executive OfficerKloten, Switzerland Find on LinkedIn ↗
-
Alexander C. Zwyer · Executive OfficerKloten, Switzerland Find on LinkedIn ↗
-
Olivier Samuel · DirectorKloten, Switzerland Find on LinkedIn ↗
-
Eran Iohan · DirectorKloten, Switzerland Find on LinkedIn ↗
-
Liora Oren · DirectorKloten, Switzerland Find on LinkedIn ↗
-
Tamar Galili · DirectorKloten, Switzerland Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗